598 related articles for article (PubMed ID: 28637869)
41. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
42. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
43. APOBEC-mediated editing of viral RNA.
Bishop KN; Holmes RK; Sheehy AM; Malim MH
Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
[TBL] [Abstract][Full Text] [Related]
44. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
Krause K; Marcu KB; Greeve J
Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
46. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems.
Zhao D; Wang X; Lou G; Peng G; Li J; Zhu H; Chen F; Li S; Liu D; Chen Z; Yang Z
Virus Res; 2010 Aug; 151(2):213-9. PubMed ID: 20510315
[TBL] [Abstract][Full Text] [Related]
47. APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y; Ma J; Kotler E; Hassan F; Botvinnik A; Smith Y; Moshel O; Nasereddin A; Sharma G; Pikarsky E; Ross S; Kotler M
FEBS J; 2023 Apr; 290(7):1822-1839. PubMed ID: 36325681
[TBL] [Abstract][Full Text] [Related]
48. Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
Caswell D; Swanton C
Cancer Res; 2023 Feb; 83(4):487-488. PubMed ID: 36789568
[TBL] [Abstract][Full Text] [Related]
49. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
[TBL] [Abstract][Full Text] [Related]
50. Nanoscale Characterization of Interaction of APOBEC3G with RNA.
Pan Y; Sun Z; Maiti A; Kanai T; Matsuo H; Li M; Harris RS; Shlyakhtenko LS; Lyubchenko YL
Biochemistry; 2017 Mar; 56(10):1473-1481. PubMed ID: 28029777
[TBL] [Abstract][Full Text] [Related]
51. Dissecting APOBEC3G substrate specificity by nucleoside analog interference.
Rausch JW; Chelico L; Goodman MF; Le Grice SF
J Biol Chem; 2009 Mar; 284(11):7047-58. PubMed ID: 19136562
[TBL] [Abstract][Full Text] [Related]
52. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
[TBL] [Abstract][Full Text] [Related]
53. Potential roles of placental human beta-defensin-3 and apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3G in prevention of intrauterine transmission of hepatitis B virus.
Bai X; Tian T; Wang P; Yang X; Wang Z; Dong M
J Med Virol; 2015 Mar; 87(3):375-9. PubMed ID: 25196417
[TBL] [Abstract][Full Text] [Related]
54. Regulation of Antiviral Innate Immunity Through APOBEC Ribonucleoprotein Complexes.
Salter JD; Polevoda B; Bennett RP; Smith HC
Subcell Biochem; 2019; 93():193-219. PubMed ID: 31939152
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
Watashi K; Liang G; Iwamoto M; Marusawa H; Uchida N; Daito T; Kitamura K; Muramatsu M; Ohashi H; Kiyohara T; Suzuki R; Li J; Tong S; Tanaka Y; Murata K; Aizaki H; Wakita T
J Biol Chem; 2013 Nov; 288(44):31715-27. PubMed ID: 24025329
[TBL] [Abstract][Full Text] [Related]
56. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription.
Chen Y; Hu J; Cai X; Huang Y; Zhou X; Tu Z; Hu J; Tavis JE; Tang N; Huang A; Hu Y
Antiviral Res; 2018 Jan; 149():16-25. PubMed ID: 29129707
[TBL] [Abstract][Full Text] [Related]
57. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
Rose KM; Marin M; Kozak SL; Kabat D
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
[TBL] [Abstract][Full Text] [Related]
58. [Inhibitory effect of a HBV vector plasmid expressing A3C on HBV replication].
Li D; Wang YM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2044-7, 2050. PubMed ID: 19861262
[TBL] [Abstract][Full Text] [Related]
59. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
60. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]